Rebel Medicine, a Salt Lake Metropolis, UT-based medical‑stage biotechnology firm, raised an undisclosed quantity in funding.
The spherical was led by Crocker Ventures with participation from Central Texas Angel Community (CTAN), Prosperity Options Capital, Utah Innovation Fund, SK Hart, the Joan & Tim Fenton Fund, Cantina Angels and angel traders.
The corporate intends to make use of the funds to speed up medical improvement of Alevatrix and produce its opioid-sparing ache therapies to sufferers sooner.
Led by CEO Brett Davis, Insurgent Medication is a privately held biotechnology firm that leverages its proprietary drug supply applied sciences to reinforce the performance of validated lively pharmaceutical components. This method results in new prolonged‑launch therapeutics that tackle pressing unmet medical wants whereas lowering improvement time, price and danger. Its lead asset, Alevatrix, is being developed for non-opioid post-operative ache administration, with extra pipeline packages in improvement that make the most of Insurgent’s proprietary supply techniques to supply extended-release of injectable medication from days to months.
FinSMEs
12/06/2025
